Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen Berenson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew R. Henn - $23K in MCRB purchases and sales in the last 12 months
- Teresa L. Young - $19K in MCRB purchases and sales in the last 12 months
- Eric D. Shaff - $9K in MCRB purchases and sales in the last 12 months
- Thomas Desrosier - $3K in MCRB purchases and sales in the last 12 months
- Kelly Brady - $735 in MCRB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen Berenson?
Stephen Berenson is a corporate insider of Seres Therapeutics, Inc. (MCRB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stephen Berenson last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 3 filings going back to 2025.